How big is the Nutrigenomics Market?

The Nutrigenomics Market size is expected to reach USD 0.69 billion in 2024 and grow at a CAGR of 15.46% to reach USD 1.42 billion by 2029. Read More

What is the current Nutrigenomics Market size?

In 2024, the Nutrigenomics Market size is expected to reach USD 0.69 billion. Read More

Who are the key players in Nutrigenomics Market?

BASF SE, Danone, Cell-Logic, DSM and Metagenics Inc. are the major companies operating in the Nutrigenomics Market. Read More

Which is the fastest growing region in Nutrigenomics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Nutrigenomics Market?

In 2024, the North America accounts for the largest market share in Nutrigenomics Market. Read More

What years does this Nutrigenomics Market cover, and what was the market size in 2023?

In 2023, the Nutrigenomics Market size was estimated at USD 0.58 billion. The report covers the Nutrigenomics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Nutrigenomics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Nutrigenomics Market - Size, Share & Growth

Nutrigenomics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Nutrigenomics Market Trends and It is Segmented by Application (Cardiovascular Diseases, Obesity, Cancer Research, and Other Applications) and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The Market Values are Provided in Terms of (USD Million) for the Above Segments.

Nutrigenomics Industry Overview

The nutrigenomics market is fragmented and competitive. The market consists of several major players. The market players with more funds for product innovation and research have established their positions in the market. Several companies are shifting their focus to the development of tailor-made foods to match a particular gene profile, such as strengthening the weak immune system and decreasing the intake of cholesterol compounds. Thus, with increasing demand for food intake and the availability of funds, new companies are entering the market, increasing the threat of new entrants from moderate to high. Some of the players in this market are DSM, BASF SE, Danone, Genova Diagnostics, Cell-Logic, Metagenics Inc., and GeneSmart, among others.